Resveratrol enhances the suppressive effects of arsenic trioxide on primitive leukemic progenitors

被引:14
作者
Wu, Edward J. [1 ]
Goussetis, Dennis J. [1 ,2 ,3 ]
Beauchamp, Elspeth [1 ,2 ]
Kosciuczuk, Ewa M. [1 ]
Altman, Jessica K. [1 ,2 ,3 ]
Eklund, Elizabeth A. [1 ,2 ,3 ]
Platanias, Leonidas C. [1 ,2 ,3 ]
机构
[1] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA
[2] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Hematol Oncol, Chicago, IL 60611 USA
[3] Jesse Brown VA Med Ctr, Dept Med, Chicago, IL USA
基金
美国国家卫生研究院;
关键词
arsenic trioxide; myeloid leukemia; apoptosis; autophagy; ACTIVATED PROTEIN-KINASE; ABL-EXPRESSING CELLS; ANTILEUKEMIC RESPONSES; CELLULAR-RESPONSES; INDUCED APOPTOSIS; MAMMALIAN TARGET; I INTERFERONS; GENERATION; CANCER; RAPAMYCIN;
D O I
10.4161/cbt.27824
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Efforts to enhance the antileukemic properties of arsenic trioxide are clinically relevant and may lead to the development of new therapeutic approaches for the management of certain hematological malignancies. We provide evidence that concomitant treatment of acute myeloid leukemia (AML) cells or chronic myeloid leukemia (CML) cells with resveratrol potentiates arsenic trioxide-dependent induction of apoptosis. Importantly, clonogenic assays in methylcellulose demonstrate potent suppressive effects of the combination of these agents on primitive leukemic progenitors derived from patients with AML or CML. Taken together, these findings suggest that combinations of arsenic trioxide with resveratrol may provide an approach for targeting of early leukemic precursors and, possibly, leukemia initiating stem cells.
引用
收藏
页码:473 / 478
页数:6
相关论文
共 35 条
[1]   Regulatory effects of mammalian target of rapamycin-mediated signals in the generation of arsenic trioxide responses [J].
Altman, Jessica K. ;
Yoon, Patrick ;
Katsoulidis, Efstratios ;
Kroczynska, Barbara ;
Sassano, Antonella ;
Redig, Amanda J. ;
Glaser, Heather ;
Jordan, Alison ;
Tallman, Martin S. ;
Hay, Nissim ;
Platanias, Leonidas C. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (04) :1992-2001
[2]   Dual mTORC2/mTORC1 Targeting Results in Potent Suppressive Effects on Acute Myeloid Leukemia (AML) Progenitors [J].
Altman, Jessica K. ;
Sassano, Antonella ;
Kaur, Surinder ;
Glaser, Heather ;
Kroczynska, Barbara ;
Redig, Amanda J. ;
Russo, Suzanne ;
Barr, Sharon ;
Platanias, Leonidas C. .
CLINICAL CANCER RESEARCH, 2011, 17 (13) :4378-4388
[3]   Critical roles for mTORC2-and rapamycin-insensitive mTORC1-complexes in growth and survival of BCR-ABL-expressing leukemic cells [J].
Carayol, Nathalie ;
Vakana, Eliza ;
Sassano, Antonella ;
Kaur, Surinder ;
Goussetis, Dennis J. ;
Glaser, Heather ;
Druker, Brian J. ;
Donato, Nicholas J. ;
Altman, Jessica K. ;
Barr, Sharon ;
Platanias, Leonidas C. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (28) :12469-12474
[4]   Regulation of arsenic trioxide-induced cellular responses by Mnk1 and Mnk2 [J].
Dolniak, Blazej ;
Katsoulidis, Efstratios ;
Carayol, Nathalie ;
Altman, Jessica K. ;
Redig, Amanda J. ;
Tallman, Martin S. ;
Ueda, Takeshi ;
Watanabe-Fukunaga, Rie ;
Fukunaga, Rikiro ;
Platanias, Leonidas C. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (18) :12034-12042
[5]  
Dörrie J, 2001, CANCER RES, V61, P4731
[6]  
Duraj J, 2006, NEOPLASMA, V53, P384
[7]   Life and death partners: apoptosis, autophagy and the cross-talk between them [J].
Eisenberg-Lerner, A. ;
Bialik, S. ;
Simon, H-U ;
Kimchi, A. .
CELL DEATH AND DIFFERENTIATION, 2009, 16 (07) :966-975
[8]   A potential role for resveratrol as a radiation sensitizer for melanoma treatment [J].
Fang, Yujiang ;
Bradley, Moore J. ;
Cook, Kathryn M. ;
Herrick, Elizabeth J. ;
Nicholl, Michael B. .
JOURNAL OF SURGICAL RESEARCH, 2013, 183 (02) :645-653
[9]   Resveratrol enhances radiation sensitivity in prostate cancer by inhibiting cell proliferation and promoting cell senescence and apoptosis [J].
Fang, Yujiang ;
DeMarco, Vincent G. ;
Nicholl, Michael B. .
CANCER SCIENCE, 2012, 103 (06) :1090-1098
[10]   Sensitization for anticancer drug-induced apoptosis by the chemopreventive agent resveratrol [J].
Fulda, S ;
Debatin, KM .
ONCOGENE, 2004, 23 (40) :6702-6711